• 2023
  Nardella F, Dobrescu I, Hassan H, Rodrigues F, Thiberge S, Mancio-Silva L, Tafit A, Jallet C, Cadet-Daniel V, Goussin S, Lorthiois A, Menon Y, Molinier N, Pechalrieu D, Long C, Sautel F, Matondo M, Duchateau M, Médard G, Witkowski B, Scherf A, Halby L, Arimondo PB , Hemisynthetic alkaloids derived from trilobine are antimalarials with sustained activity in multidrug-resistant Plasmodium falciparum., iScience 2023 Feb; 26(2): 105940.
• 2022
  Erdmann D, Contreras J, Le Meur RA, Vitorge B, Saverat V, Tafit A, Jallet C, Cadet-Daniel V, Bon C, Phansavath P, Ratovelomanana-Vidal V, Jeltsch A, Vichier-Guerre S, Guijarro JI, Arimondo PB, , Identification of Chemical Probes Targeting MBD2., ACS Chem Biol 2022.
• 2022
  Bon C, Barbachowska M, Djokovic N, Ruzic D, Si Y, Soresinetti L, Jallet C, Tafit A, Halby L, Nikolic K, Arimondo PB, , Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studies., Future Med Chem 2022 04; 14(8): 557-570.
• 2021
  Sabrina Kalia, Corinne Jallet, Saliha Azebi, Thomas Cokelaer, Juliana Pipoli Da Fonseca, Yu Wu, Julien Barbier , Jean-Christophe Cintrat, Daniel Gillet, Noël Tordo, Broad spectrum compounds targeting early stages of RABV infection, Antiviral Res 188 (2021) 105016.
• 2013
  Gibert R, Alberti M, Poirier B, Jallet C, Tordo N, Morgeaux S, A relevant in vitro ELISA test in alternative to the in vivo NIH test for human rabies vaccine batch release, Vaccine 2013 Dec;31(50):6022-9.
• 2010
  Bouet-Cararo C, Contreras V, Fournier A, Jallet C, Guibert JM, Dubois E, Thiery R, Bréard E, Tordo N, Richardson J, Schwartz-Cornil I, Zientara S, Klonjkowski B, Canine adenoviruses elicit both humoral and cell-mediated immune responses against rabies following immunisation of sheep, Vaccine 2011 Feb;29(6):1304-10.
• 2009
  Castel G, Chtéoui M, Caignard G, Préhaud C, Méhouas S, Réal E, Jallet C, Jacob Y, Ruigrok RW, Tordo N, Peptides that mimic the amino-terminal end of the rabies virus phosphoprotein have antiviral activity, J. Virol. 2009 Oct;83(20):10808-20.
• 2008
  Tordo N, Foumier A, Jallet C, Szelechowski M, Klonjkowski B, Eloit M, Canine adenovirus based rabies vaccines, Dev Biol (Basel) 2008;131:467-76.
• 2006
  Tordo N, Bahloul C, Jacob Y, Jallet C, Perrin P, Badrane H, Rabies: epidemiological tendencies and control tools, Dev Biol (Basel) 2006;125:3-13.
• 2005
  Nagarajan T, Reddy GS, Mohana Subramanian B, Rajalakshmi S, Thiagarajan D, Tordo N, Jallet C, Srinivasan VA, A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture, Biologicals 2006 Mar;34(1):21-7.
• 2004
  Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y, Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides, J. Virol. 2004 Jul;78(14):7410-7.
• 2003
  Fournier-Caruana J, Poirier B, Haond G, Jallet C, Fuchs F, Tordo N, Perrin P, Inactivated rabies vaccine control and release: use of an ELISA method, Biologicals 2003 Mar;31(1):9-16.
• 2001
  Tuffereau C, Desmézières E, Bénéjean J, Jallet C, Flamand A, Tordo N, Perrin P, Interaction of lyssaviruses with the low-affinity nerve-growth factor receptor p75NTR, J. Gen. Virol. 2001 Dec;82(Pt 12):2861-7.
• 1999
  Perrin P, Jacob Y, Aguilar-Sétien A, Loza-Rubio E, Jallet C, Desmézières E, Aubert M, Cliquet F, Tordo N, Immunization of dogs with a DNA vaccine induces protection against rabies virus, Vaccine 1999 Oct;18(5-6):479-86.
• 1999
  Drings A, Jallet C, Chambert B, Tordo N, Perrin P, Is there an advantage to including the nucleoprotein in a rabies glycoprotein subunit vaccine?, Vaccine 1999 Mar;17(11-12):1549-57.
• 1999
  Jallet C, Jacob Y, Bahloul C, Drings A, Desmezieres E, Tordo N, Perrin P, Chimeric lyssavirus glycoproteins with increased immunological potential, J. Virol. 1999 Jan;73(1):225-33.
• 1996
  Perrin P, Tino de Franco M, Jallet C, Fouque F, Morgeaux S, Tordo N, Colle JH, The antigen-specific cell-mediated immune response in mice is suppressed by infection with pathogenic lyssaviruses, Res. Virol. 1996 Sep-Oct;147(5):289-99.